Brigatinib Post Definitive Chemo-radiotherapy in Patients with ALK-fusion Non-small Cell Lung Cancer
Clinical trial NCT05718297 · WITHDRAWN
Trial details
- NCT number
- NCT05718297
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-07
- Primary completion
- 2024-09-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.